beijing leadingpharm medicine technology development-凯发官方

leadingpharm was established in 2005 and was listed on the shanghai stock exchange in 2015 (stock code: 600222). it is a high-tech enterprise providing pharmacy preclinical research, clinical cro and cdmo services to the world. it has been rated as one of the "top ten chinese pharmaceutical r&d companies (ranked no. 1 in 2019/2020)" for many years. the company is headquartered in beijing zhongguancun high-tech park and has established new drug screening and testing platform, drug evaluation platform (animal room, certified by glp, aaalac, cnas), large molecule pilot and large-scale production platform, small molecule cmc research and production platform, cell technology platform and clinical cro platform in lifezhengzhou. the six platforms comply with international standards (fda, ema and nmpagmp) , forming leadingpharm cxo whole industry chain service system. the combination of imitation and creation, driven by dual engines, can provide customers with diversified services throughout the pharmaceutical research and development.